Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer
Crossref DOI link: https://doi.org/10.1007/s10147-016-0984-y
Published Online: 2016-05-03
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shimada, Muneaki
Sato, Shinya
Oishi, Tetsuro
Itamochi, Hiroaki
Kigawa, Junzo
Takeshima, Nobuhiro
Aoki, Daisuke
Aoki, Yoichi
Nambu, Yoshihiro
Ochiai, Kazunori
Text and Data Mining valid from 2016-05-03